Orticumab (Synonyms:奥替苏单抗)
目录号 : KM38569 CAS No. : 1314241-10-5 纯度 : ≥99%
Orticumab (MLDL1278A) 是一种靶向氧化或丙二醛修饰的脂蛋白 (LDL) 的抗体。Orticumab 特异性抑制氧化低密度脂蛋白 (oxLDL)。Orticumab 参与调节针对 oxLDL 的自身免疫反应,可改善动物模型的动脉粥样硬化。Orticumab 也可用于改善银屑病的研究。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement.
分子量
143.68 kDa
CAS号
1314241-10-5
中文名称
奥替苏单抗
运输条件
Shipping with dry ice.
储存方式
Store at -20˚C 
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2